|
GLS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99840144432528E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65367719517917E-12 |
| Normal-vs-Stage2 |
2.40807374041196E-13 |
| Normal-vs-Stage3 |
1.62481139653892E-12 |
| Normal-vs-Stage4 |
7.7715611723761E-16 |
| Stage1-vs-Stage2 |
4.651600E-01 |
| Stage1-vs-Stage3 |
4.686400E-02 |
| Stage1-vs-Stage4 |
1.122000E-01 |
| Stage2-vs-Stage3 |
5.403400E-01 |
| Stage2-vs-Stage4 |
5.697600E-01 |
| Stage3-vs-Stage4 |
9.733800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88178419700125E-16 |
| Normal-vs-AfricanAmerican |
2.46730003095053E-09 |
| Normal-vs-Asian |
3.566400E-02 |
| Caucasian-vs-AfricanAmerican |
4.039800E-01 |
| Caucasian-vs-Asian |
2.934200E-01 |
| AfricanAmerican-vs-Asian |
4.089400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
9.18254361437221E-12 |
| Male-vs-Female |
4.62779999998997E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6796564139554E-12 |
| Normal-vs-Age(41-60Yrs) |
3.66373598126302E-15 |
| Normal-vs-Age(61-80Yrs) |
3.21964677141295E-15 |
| Normal-vs-Age(81-100Yrs) |
1.72870000536562E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.895000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.777400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.484200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.809000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.299200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.194000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.741800E-03 |
| Normal-vs-Grade 2 |
1.63125069008174E-12 |
| Normal-vs-Grade 3 |
1.62858615482264E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
4.028400E-01 |
| Grade 1-vs-Grade 3 |
3.801400E-01 |
| Grade 1-vs-Grade 4 |
1.934160E-01 |
| Grade 2-vs-Grade 3 |
8.317200E-01 |
| Grade 2-vs-Grade 4 |
6.515800E-02 |
| Grade 3-vs-Grade 4 |
7.320100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.30948593582525E-12 |
| Normal-vs-ccB subtype |
1.11022302462516E-16 |
| ccA subtype-vs-ccB subtype |
1.341110E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.88258347483861E-15 |
| Normal-vs-N1 |
1.0024999996805E-07 |
| N0-vs-N1 |
8.440200E-01 |
|
|
|
GLS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99840144432528E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65367719517917E-12 |
| Normal-vs-Stage2 |
2.40807374041196E-13 |
| Normal-vs-Stage3 |
1.62481139653892E-12 |
| Normal-vs-Stage4 |
7.7715611723761E-16 |
| Stage1-vs-Stage2 |
4.651600E-01 |
| Stage1-vs-Stage3 |
4.686400E-02 |
| Stage1-vs-Stage4 |
1.122000E-01 |
| Stage2-vs-Stage3 |
5.403400E-01 |
| Stage2-vs-Stage4 |
5.697600E-01 |
| Stage3-vs-Stage4 |
9.733800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88178419700125E-16 |
| Normal-vs-AfricanAmerican |
2.46730003095053E-09 |
| Normal-vs-Asian |
3.566400E-02 |
| Caucasian-vs-AfricanAmerican |
4.039800E-01 |
| Caucasian-vs-Asian |
2.934200E-01 |
| AfricanAmerican-vs-Asian |
4.089400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
9.18254361437221E-12 |
| Male-vs-Female |
4.62779999998997E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6796564139554E-12 |
| Normal-vs-Age(41-60Yrs) |
3.66373598126302E-15 |
| Normal-vs-Age(61-80Yrs) |
3.21964677141295E-15 |
| Normal-vs-Age(81-100Yrs) |
1.72870000536562E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.895000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.777400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.484200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.809000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.299200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.194000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.741800E-03 |
| Normal-vs-Grade 2 |
1.63125069008174E-12 |
| Normal-vs-Grade 3 |
1.62858615482264E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
4.028400E-01 |
| Grade 1-vs-Grade 3 |
3.801400E-01 |
| Grade 1-vs-Grade 4 |
1.934160E-01 |
| Grade 2-vs-Grade 3 |
8.317200E-01 |
| Grade 2-vs-Grade 4 |
6.515800E-02 |
| Grade 3-vs-Grade 4 |
7.320100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.30948593582525E-12 |
| Normal-vs-ccB subtype |
1.11022302462516E-16 |
| ccA subtype-vs-ccB subtype |
1.341110E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.88258347483861E-15 |
| Normal-vs-N1 |
1.0024999996805E-07 |
| N0-vs-N1 |
8.440200E-01 |
|
|
